Brief exposure to secondhand smoke reversibly impairs endothelial vasodilatory function
Kranthi Pinnamaneni1, Richard E Sievers, Rikki Sharma
1Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA;
Summary
Brief exposure to secondhand smoke (SHS) significantly impairs arterial flow-mediated dilation (FMD), a key indicator of vascular health. Even one minute of SHS exposure can reduce endothelial function, highlighting the risks of even short smoke encounters.
Area of Science:
- Cardiovascular Physiology
- Environmental Health
- Toxicology
Background:
- Secondhand smoke (SHS) exposure is a known health risk.
- Understanding acute effects of low-concentration SHS on vascular function is crucial.
- Previous studies indicate SHS impairs flow-mediated dilation (FMD) in humans.
Purpose of the Study:
- To determine the impact of brief, low-concentration SHS exposure on arterial FMD.
- To investigate the dose-response relationship between SHS exposure duration/concentration and FMD impairment.
- To establish a controlled animal model for studying acute SHS effects.
Main Methods:
- Rats, never previously exposed to smoke, were subjected to varying durations (30 min, 10 min, 1 min, 4 breaths) of real-world SHS levels.
- Arterial flow-mediated dilation (FMD) was measured as a marker of endothelial function.
- A dose-response relationship was analyzed between SHS particle concentration and FMD changes.
Main Results:
- A linear dose-response relationship was observed between SHS concentration over 30 min and FMD impairment, saturating at higher levels.
- Exposure to SHS for as little as 1 minute at moderate concentrations was sufficient to impair FMD.
- Impairment of FMD was observed across a range of real-world SHS concentrations.
Conclusions:
- Brief exposures to SHS at levels encountered in real-world settings reversibly impair endothelial function, as measured by FMD.
- Even minimal SHS exposure (1 minute) can significantly reduce FMD.
- These findings underscore the immediate vascular risks associated with SHS.
More Related Videos
09:40Ultrasound Assessment of Flow-Mediated Dilation of the Brachial and Superficial Femoral Arteries in Rats
Published on: November 3, 2016
11.1K
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
11.3K
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
01:26Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
01:23Chronic Obstructive Pulmonary Disease I: Introduction
33
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
33
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
01:29Stimulants
1.4K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.4K